577 related articles for article (PubMed ID: 30567985)
21. Correlations between vaccinia-specific immune responses within a cohort of armed forces members.
Umlauf BJ; Ovsyannikova IG; Haralambieva IH; Kennedy RB; Vierkant RA; Pankratz VS; Jacobson RM; Poland GA
Viral Immunol; 2011 Oct; 24(5):415-20. PubMed ID: 21958369
[TBL] [Abstract][Full Text] [Related]
22. Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus.
Shchelkunov SN; Sergeev AA; Yakubitskiy SN; Titova KA; Pyankov SA; Kolosova IV; Starostina EV; Borgoyakova MB; Zadorozhny AM; Kisakov DN; Shulgina IS; Karpenko LI
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452494
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of CD8+ T cell immunity in the lung by CpG oligodeoxynucleotides increases protective efficacy of a modified vaccinia Ankara vaccine against lethal poxvirus infection even in a CD4-deficient host.
Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Klinman D; Berzofsky JA
J Immunol; 2006 Nov; 177(9):6336-43. PubMed ID: 17056564
[TBL] [Abstract][Full Text] [Related]
24. Deletion of major nonessential genomic regions in the vaccinia virus Lister strain enhances attenuation without altering vaccine efficacy in mice.
Dimier J; Ferrier-Rembert A; Pradeau-Aubreton K; Hebben M; Spehner D; Favier AL; Gratier D; Garin D; Crance JM; Drillien R
J Virol; 2011 May; 85(10):5016-26. PubMed ID: 21367889
[TBL] [Abstract][Full Text] [Related]
25. E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox.
Volz A; Jany S; Freudenstein A; Lantermann M; Ludwig H; Sutter G
Viruses; 2018 Jan; 10(1):. PubMed ID: 29300297
[TBL] [Abstract][Full Text] [Related]
26. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
Ryerson MR; Shisler JL
Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
[TBL] [Abstract][Full Text] [Related]
27. Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain.
Wang Y; Kan S; Du S; Qi Y; Wang J; Liu L; Ji H; He D; Wu N; Li C; Chi B; Li X; Jin N
Antiviral Res; 2012 Dec; 96(3):324-32. PubMed ID: 23084929
[TBL] [Abstract][Full Text] [Related]
28. Vaccination with recombinant modified vaccinia virus Ankara prevents the onset of intestinal allergy in mice.
Bohnen C; Wangorsch A; Schülke S; Nakajima-Adachi H; Hachimura S; Burggraf M; Süzer Y; Schwantes A; Sutter G; Waibler Z; Reese G; Toda M; Scheurer S; Vieths S
Allergy; 2013 Aug; 68(8):1021-8. PubMed ID: 23909913
[TBL] [Abstract][Full Text] [Related]
29. Antitumor activity and immune responses induced by a recombinant carcinoembryonic antigen-vaccinia virus vaccine.
Kantor J; Irvine K; Abrams S; Kaufman H; DiPietro J; Schlom J
J Natl Cancer Inst; 1992 Jul; 84(14):1084-91. PubMed ID: 1619682
[TBL] [Abstract][Full Text] [Related]
30. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of modified vaccinia Ankara (MVA) as a potential replacement smallpox vaccine.
Phelps AL; Gates AJ; Hillier M; Eastaugh L; Ulaeto DO
Vaccine; 2007 Jan; 25(1):34-42. PubMed ID: 16950548
[TBL] [Abstract][Full Text] [Related]
32. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
[TBL] [Abstract][Full Text] [Related]
33. Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.
Wyatt LS; Earl PL; Eller LA; Moss B
Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4590-5. PubMed ID: 15070762
[TBL] [Abstract][Full Text] [Related]
34. Mosaic H5 Hemagglutinin Provides Broad Humoral and Cellular Immune Responses against Influenza Viruses.
Kamlangdee A; Kingstad-Bakke B; Osorio JE
J Virol; 2016 Aug; 90(15):6771-6783. PubMed ID: 27194759
[TBL] [Abstract][Full Text] [Related]
35. Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding protein.
Falivene J; Del Médico Zajac MP; Pascutti MF; Rodríguez AM; Maeto C; Perdiguero B; Gómez CE; Esteban M; Calamante G; Gherardi MM
PLoS One; 2012; 7(2):e32220. PubMed ID: 22384183
[TBL] [Abstract][Full Text] [Related]
36. Development of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infection.
Knitlova J; Hajkova V; Voska L; Elsterova J; Obrova B; Melkova Z
PLoS One; 2014; 9(12):e114374. PubMed ID: 25486419
[TBL] [Abstract][Full Text] [Related]
37. Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.
Drexler I; Staib C; Kastenmuller W; Stevanović S; Schmidt B; Lemonnier FA; Rammensee HG; Busch DH; Bernhard H; Erfle V; Sutter G
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):217-22. PubMed ID: 12518065
[TBL] [Abstract][Full Text] [Related]
38. Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression.
Marín MQ; Pérez P; Gómez CE; Sorzano CÓS; Esteban M; García-Arriaza J
Viruses; 2018 Aug; 10(8):. PubMed ID: 30096846
[TBL] [Abstract][Full Text] [Related]
39. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
[TBL] [Abstract][Full Text] [Related]
40. Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.
Sánchez-Sampedro L; Gómez CE; Mejías-Pérez E; Pérez-Jiménez E; Oliveros JC; Esteban M
J Virol; 2013 Jun; 87(12):6955-74. PubMed ID: 23596295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
